Scherle Peggy has filed 3 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 230000 shares of Prelude Therapeutics Inc ($PRLD) on February 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Prelude Therapeutics Inc | $PRLD | Scherle Peggy | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 76,132,337 | 9999.99% | 0.30% |
| Feb. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Scherle Peggy | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 75,805,840 | 9999.99% | 0.23% |
| March 1, 2024 | Prelude Therapeutics Inc | $PRLD | Scherle Peggy | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 60,357,052 | 9999.99% | 0.25% |